Blomqvist, Carl
Vehmanen, Leena http://orcid.org/0000-0003-0123-1313
Kellokumpu-Lehtinen, Pirkko-Liisa
Huovinen, Riikka
Ruohola, Johanna
Penttinen, Heidi
Sievänen, Harri
Nikander, Riku
Utriainen, Meri
Saarto, Tiina
Clinical trials referenced in this document:
Documents that mention this clinical trial
Long-term effects of aromatase inhibitor withdrawal on bone mineral density in early breast cancer patients: 10-year follow-up results of the BREX study
https://doi.org/10.1007/s10549-024-07252-7
Funding for this research was provided by:
Cancer Society of Finland
Finnish Cancer Foundation
Academy of Finland
Comprehensive Cancer Center of Helsinki University Central Hospital
Kela
Finnish Ministry of Education
Finska Läkaresällskapet
Special Government Grant for Health Science Research
Helander Foundation
Paulon Säätiö
Suomen Kulttuurirahasto
Medical Fund of the Pirkanmaa Hospital District and Finnish Breast Cancer Group
Astra Zeneca
University of Helsinki
Article History
Received: 7 November 2023
Accepted: 5 January 2024
First Online: 1 April 2024
Declarations
:
: The authors have no relevant financial or non-financial interests to disclose.
: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics committee of Helsinki University Hospital. The trial was registered in the Helsinki and Uusimaa Hospital District Clinical Trials Register (; 210590) and .
: Informed consent was obtained from all individual participants included in the study.
: The authors affirm that the manuscript does not contain any individual person’s data in any form.